3138 results for «714»
3138 results
Technical challenges and optimal device choice for complex TAVI procedures
18 Feb 2023 – From PCR Tokyo Valves 2023
This session reflects on the importance of device choice and implantation technique in complex TAVI procedures. Uncover challenges in TAVI for failed bioprostheses and bicuspid aortic valves, emphasising optimal device selection and exploring the latest evolutions in TAVI such as the Medtronic.
Bicuspid valves - Imaging, sizing and technical considerations for success
18 Feb 2023 – From PCR Tokyo Valves 2023
Watch this session to learn more about bicuspid aortic valves: understand the anatomical considerations that define patient selection, explore contemporary sizing strategies and participate in case-based discussions that highlight treatment strategies for bicuspid aortic stenosis.
Predictability and control: Evolut procedural approaches
18 Feb 2023 – From PCR Tokyo Valves 2023
In this session, delve into Evolut procedural approaches. You will be examining the cusp overlap technique, its latest clinical data and outcomes of the Medtronic's newest generational technology: Evolut FX.
Factors to consider during lifetime planning for TAVI patients
19 Feb 2023 – From PCR Tokyo Valves 2023
In this session, explore factors influencing lifetime prognosis and complication avoidance strategies in TAVI patients, focusing on pacemaker and paravalvular leak risk factors.
Clinical cases - Coronary interventions - Session 3
06 Oct 2022 – From AICT-AsiaPCR 2022
Left main - DK crush stenting: LIVE case from National University Heart Centre - Singapore
06 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 2
06 Oct 2022 – From AICT-AsiaPCR 2022
Abstracts - Coronary interventions - Session 1
06 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 1
06 Oct 2022 – From AICT-AsiaPCR 2022
Welcome to GulfPCR Valves 2023
05 Dec 2023 – From GulfPCR-GIM 2023
Find out more about this very first edition of GulfPCR Valves by discovering its Course directors, its objectives, its programme, its partners and its interactivity. If you are a heart valve interventionist or an imager, and you have a keen interest in valve disease, and TAVI in...
TAVI for bicuspid aortic stenosis patients - Recorded cases
05 Dec 2023 – From GulfPCR-GIM 2023
Discover two clinical cases of optimising TAVI procedure in bicuspid aortic valve patients, taking into account the current sizing options in such anatomy.
- An 84-year-old woman with a history of LAD PCI in 2020, presented a symptomatic severe aortic stenosis and grade 3 regurgitation with a preserved LV...
TAVI and access: alternating is wise
16 Jan 2024 – From GulfPCR-GIM 2023
Given that 10-20% of patients have restricted or even impossible femoral access, it is important, for both procedural and patient safety, that alternative access is sometimes considered. Learn what options are available, whether surgical or transcatheter, depending on the patient, and how to put these choices into...
Newer generation self-expanding platform: technical optimisation for common clinical challenges
05 Dec 2023 – From GulfPCR-GIM 2023
The primary focus of this GulfPCR-GIM 2023 session revolves around pre-procedural planning considerations, valve selection, and managing complex anatomies using both traditional self-expanding valves and the Evolut FX system. Additionally, the session aims to explore the work-up protocol for patients grappling with severe AS and advanced...
Essentials of lifetime management of TAVR patients using novel Myval THV
05 Dec 2023 – From GulfPCR-GIM 2023
Join this GulfPCR-GIM 2023 session to explore the Myval next-generation THV technology, uncovering its unique features, procedural advantages, and clinical benefits, from extensive patient data. Learn also about the CorAlign technique that ensures precise commissural and coronary alignment while preserving coronary access, and gain insights into...
Evidence gap and new indications
05 Dec 2023 – From GulfPCR-GIM 2023
Follow discussions about a 74-year-old patient with NYHA III.IV dyspnea, DM, HTN, paroxismal AF and LVEF 20% to find out more about symptomatic moderate aortic stenosis, and about an 84-year-old patient with dyspnea NYHA III, HTN, no significant CAD, and follow-up for moderate aortic regurgitation, and...
Valve-in-valve: not as simple as it looks
05 Dec 2023 – From GulfPCR-GIM 2023
Thanks to this session, you will enhance your comprehension of anticipating, planning, and executing TAV-in-TAV procedures, and gain insights into preventing coronary obstruction during these interventions.
From access to annulus: overcoming challenging anatomies
05 Dec 2023 – From GulfPCR-GIM 2023
Gain expertise in selecting the appropriate TAVI device for achieving stable deployment in a 90-degree horizontal aorta. Discover techniques for ensuring smooth deliverability, particularly when navigating through tight and tortuous anatomies. Additionally, learn strategies to prepare for future coronary access, irrespective of the height of the...
GulfPCR-GIM 2023 Opening Ceremony
06 Dec 2023 – From GulfPCR-GIM 2023
After a short presentation of the Course Directors and co-Directors, as well as the programme committee Members, find out more about the program, content and new features of this two-day Course, and learn more about the "GulfWIN" initiative, launched last year, which puts women at the heart...
Challenging scenarios in cardiogenic shock
06 Dec 2023 – From GulfPCR-GIM 2023
Thanks to this session, explore the physiology and stages of cardiogenic shock and diverse modalities for its treatment, and acquire proficiency in managing patients undergoing high-risk PCI with cardiogenic shock.
Challenging scenarios in STEMI patients
06 Dec 2023 – From GulfPCR-GIM 2023
This session tackles complex scenarios encountered in STEMI interventions, ranging from conditions affecting the left main stem (LMS) to managing extensive thrombus burdens, explore strategies when patients have a history of previous stents, address treatment approaches for those with multivessel disease, and deliberate on strategies when...
